Prescription drug cost barriers are increasingly causing people to divert from doctor-recommended treatment plans.

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

Newly back in the CEO chair at UnitedHealth Group, Stephen Hemsley on Monday vowed to address a series of lightning-rod ...

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory ...

The act targets the health insurance middlemen that manage members' prescription drug benefits on behalf of the plans, ...

UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory ...